HitGen (688222.SS) Stock Price

HitGen Price

CLOSED
44.69
​
Market closed

Over the last 8 years HitGen grew revenue by 33.1% annually, reaching 525.57 M CNY. Earnings per share have declined at 2.2% per year over the last 7 years. For HitGen, the net margin of 20.8% is broadly stable versus 20.4% a few years ago. At today's price the dividend yield works out to roughly 0.13%. The payout ratio is around 22% of earnings. The consensus 12-month price target for HitGen is 27.74 CNY, about 37.9% below where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

HitGen stock price

Access this data via the Eulerpool API

HitGen business model & stock analysis

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.

Frequently asked questions about HitGen

Analysts currently set an average price target of 27.74 CNY for the HitGen stock (median: 27.74 CNY), implying -37.9 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the HitGen stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect HitGen to generate revenue of 690.15 M CNY and earnings per share of 0.37 CNY.

Converted at the current exchange rate, the HitGen share trades at 5.95 EUR (44.69 CNY).

The expected revenue of HitGen is 690.15 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of HitGen is 148.25 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of HitGen is currently 120.78. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the HitGen stock.

The price-to-sales ratio (P/S) of HitGen is currently 25.95. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the HitGen stock.

The Eulerpool Quality Score for HitGen is 2/10.

The ISIN of HitGen is CNE1000040G3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of HitGen is 688222.SS. The ticker symbol is used to trade HitGen shares on the stock exchange.

Fair ValueTerminal
43.35 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
1.03 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hitgen.com
Country
Currency
CNY
Initial public offering
Apr 16, 2020
ISIN
CNE1000040G3
Cusip
Y322GW103
Market capitalization
17.91 B CNYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
120.78
P/Ee 2027
81.55
P/Ee 2028
—
P/Ee 2029
—
P/Ee 2030
—
P/Se
25.95
EV/EBIT
131.25
P/B Ratio
11.93
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.68 %
Dividend
Dividend yield
0.13 %
Est. Dividend Yield
0.13 %
Payout Ratio
21.95 %
Dividend growth Ø5Y
-13.65 %
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
10.00 %
Last updated Oct 8, 2026, 5:20 PM

HitGen Peer Group

HitGen FIGI

688222:CG · BBG00PNX8F13688222:CH · BBG00L1B3LF1688222:C1 · BBG01GZT7FP3

All fundamentals and in-depth analysis of HitGen

Our stock analysis for HitGen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HitGen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.